[go: up one dir, main page]

SG10201503534RA - Monitoring health and disease status using clonotype profiles - Google Patents

Monitoring health and disease status using clonotype profiles

Info

Publication number
SG10201503534RA
SG10201503534RA SG10201503534RA SG10201503534RA SG10201503534RA SG 10201503534R A SG10201503534R A SG 10201503534RA SG 10201503534R A SG10201503534R A SG 10201503534RA SG 10201503534R A SG10201503534R A SG 10201503534RA SG 10201503534R A SG10201503534R A SG 10201503534RA
Authority
SG
Singapore
Prior art keywords
disease status
monitoring health
clonotype profiles
clonotype
profiles
Prior art date
Application number
SG10201503534RA
Inventor
Malek Faham
Thomas Willis
Original Assignee
Sequenta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44903937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201503534R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sequenta Inc filed Critical Sequenta Inc
Publication of SG10201503534RA publication Critical patent/SG10201503534RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/5052—Cells of the immune system involving B-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG10201503534RA 2010-05-06 2011-05-04 Monitoring health and disease status using clonotype profiles SG10201503534RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33217510P 2010-05-06 2010-05-06
US45574310P 2010-10-25 2010-10-25
US201161446822P 2011-02-25 2011-02-25

Publications (1)

Publication Number Publication Date
SG10201503534RA true SG10201503534RA (en) 2015-06-29

Family

ID=44903937

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201503534RA SG10201503534RA (en) 2010-05-06 2011-05-04 Monitoring health and disease status using clonotype profiles
SG2012081527A SG185128A1 (en) 2010-05-06 2011-05-04 Monitoring health and disease status using clonotype profiles

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012081527A SG185128A1 (en) 2010-05-06 2011-05-04 Monitoring health and disease status using clonotype profiles

Country Status (9)

Country Link
EP (4) EP3456847B1 (en)
JP (4) JP6085249B2 (en)
CN (2) CN103097888B (en)
AU (1) AU2011249041B2 (en)
CA (1) CA2798431C (en)
DK (2) DK2567226T3 (en)
ES (2) ES2593614T3 (en)
SG (2) SG10201503534RA (en)
WO (2) WO2011139372A1 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP4335932A3 (en) 2008-11-07 2024-06-26 Adaptive Biotechnologies Corporation Methods of monitoring conditions by sequence analysis
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9394567B2 (en) 2008-11-07 2016-07-19 Adaptive Biotechnologies Corporation Detection and quantification of sample contamination in immune repertoire analysis
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
PL2387627T3 (en) 2009-01-15 2016-10-31 Adaptive immunity profiling and methods for generation of monoclonal antibodies
JP2012531202A (en) 2009-06-25 2012-12-10 フレッド ハチンソン キャンサー リサーチ センター How to measure adaptive immunity
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
US20140057799A1 (en) 2010-12-16 2014-02-27 Gigagen System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
KR20140024270A (en) 2010-12-30 2014-02-28 파운데이션 메디신 인코포레이티드 Optimization of multigene analysis of tumor samples
US20120183969A1 (en) * 2011-01-14 2012-07-19 Jian Han Immunodiversity Assessment Method and Its Use
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9279159B2 (en) 2011-10-21 2016-03-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
EP2788509B1 (en) * 2011-12-09 2018-07-11 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
JP2015504661A (en) * 2011-12-20 2015-02-16 シーケンタ インコーポレイテッド Monitoring of transformation from follicular lymphoma to diffuse large B-cell lymphoma by immunorepertoire analysis
ES2662128T3 (en) * 2012-03-05 2018-04-05 Adaptive Biotechnologies Corporation Determination of paired immune receptor chains from the frequency of matching subunits
JP2015512655A (en) * 2012-04-13 2015-04-30 シーケンタ インコーポレイテッド Detection and quantification of sample contamination in immune repertoire analysis
MX354329B (en) 2012-05-08 2018-02-27 Adaptive Biotechnologies Corp Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions.
US20150247201A1 (en) * 2012-05-31 2015-09-03 Malek Faham Predicting relapse of chronic lymphocytic leukemia patients treated by allogeneic stem cell transplantation
SG11201408128WA (en) * 2012-06-15 2015-01-29 Adaptive Biotechnologies Corp Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
JP2015524282A (en) * 2012-08-10 2015-08-24 シーケンタ インコーポレイテッド Sensitive mutation detection using sequence tags
US20160002731A1 (en) 2012-10-01 2016-01-07 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
WO2015160439A2 (en) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
JP2015535178A (en) * 2012-10-19 2015-12-10 シーケンタ・インコーポレイテッド Chronotype monitoring of plasma cell proliferation disorders in peripheral blood
WO2014066184A1 (en) * 2012-10-22 2014-05-01 Sequenta, Inc. Monitoring mantle cell lymphoma clonotypes in peripheral blood after immunotransplant
KR102228488B1 (en) * 2013-02-11 2021-03-15 씨비 바이오테크놀로지스, 인크. Method for evaluating an immunorepertoire
AU2014218910A1 (en) * 2013-02-22 2015-08-20 Adaptive Biotechnologies Corp. Rare clonotypes and uses thereof
EP2971105B1 (en) * 2013-03-15 2018-08-01 Adaptive Biotechnologies Corporation Method of identifying adaptive immune receptor pairs
US9816088B2 (en) 2013-03-15 2017-11-14 Abvitro Llc Single cell bar-coding for antibody discovery
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
CN106103711A (en) * 2013-11-21 2016-11-09 组库创世纪株式会社 System and the application in treatment and diagnosis thereof are analyzed in φt cell receptor and B-cell receptor storehouse
CA2941612A1 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
US10202640B2 (en) 2014-05-07 2019-02-12 The Board Of Trustees Of The Leland Stanford Junior University Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
NZ730044A (en) 2014-09-15 2024-08-30 Abvitro Llc High-throughput nucleotide library sequencing
ES2784343T3 (en) 2014-10-29 2020-09-24 Adaptive Biotechnologies Corp Simultaneous, highly multiplexed detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
EP3498866A1 (en) 2014-11-25 2019-06-19 Adaptive Biotechnologies Corp. Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
EP3227464B1 (en) 2014-12-05 2022-04-20 Foundation Medicine, Inc. Multigene analysis of tumor samples
AU2016222788B2 (en) 2015-02-24 2022-03-31 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
US9422547B1 (en) 2015-06-09 2016-08-23 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires
CN106557536B (en) * 2015-09-30 2021-12-21 松下知识产权经营株式会社 Control method
US10130658B2 (en) * 2015-12-18 2018-11-20 Provectus Pharmatech, Inc. Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
CN107955831A (en) * 2016-10-13 2018-04-24 深圳华大基因研究院 The label and lymphocyte quantitative detecting method quantitatively detected for lymphocyte
GB201618485D0 (en) * 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
FI3552126T3 (en) * 2016-12-09 2025-07-08 Regeneron Pharma Systems and methods for sequencing t cell receptors and uses thereof
RU2674994C2 (en) * 2016-12-29 2018-12-14 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Method for determining markers of presence of tumor t-lymphoblasts
EP3676399B1 (en) 2017-09-01 2022-05-11 Life Technologies Corporation Compositions and methods for immune repertoire sequencing
JP7207661B2 (en) 2017-10-10 2023-01-18 国立大学法人広島大学 Technology for complete replacement of T-cell receptors using platinum TALENs
EP3702454A4 (en) 2017-10-10 2021-08-04 Hiroshima University METHOD FOR GENERATING ANTIGEN-SPECIFIC REGULATORY T-CELLS (TREG) WITH EFFECTOR T-CELL (TEFF) ANTIGEN RECEPTORS
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
WO2019196088A1 (en) * 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of obtaining tumor-specific t cell receptors
SG11202011696TA (en) 2018-06-11 2020-12-30 Foundation Medicine Inc Compositions and methods for evaluating genomic alterations
JP7145980B2 (en) * 2018-06-15 2022-10-03 エフ．ホフマン－ラ ロシュ アーゲー System for identifying antigens recognized by T-cell receptors expressed on tumor-infiltrating lymphocytes
US12473663B2 (en) 2018-07-18 2025-11-18 Life Technologies Corporation Compositions and methods for immune repertoiresequencing
CN109002689B (en) * 2018-07-23 2020-10-09 西安交通大学医学院第一附属医院 T cell data processing method and device
WO2020102721A1 (en) * 2018-11-16 2020-05-22 Rapa Therapeutics, Llc Immune monitoring of neuro-inflammatory amyotrophic lateral sclerosis (als)
EP3899039A4 (en) * 2018-12-20 2022-09-14 The Johns Hopkins University Treating type 1 diabetes, other autoimmune diseases
WO2020191365A1 (en) 2019-03-21 2020-09-24 Gigamune, Inc. Engineered cells expressing anti-viral t cell receptors and methods of use thereof
CN110988364A (en) * 2019-12-31 2020-04-10 天津美瑞特医疗科技有限公司 Method for detecting GVHD (GVHD-associated cytokine) after transplantation by using flow cytometry and detection kit
WO2021151114A1 (en) * 2020-01-22 2021-07-29 Life Technologies Corporation Immune repertoire biomarkers in autoimmune disease and immunodeficiency disorders
CN111808195A (en) * 2020-06-30 2020-10-23 中国科学院心理研究所 A method for obtaining B cell antibody gene against N-methyl-D-aspartate receptor encephalitis and its immune repertoire
CN111524548B (en) * 2020-07-03 2020-10-23 至本医疗科技（上海）有限公司 Method, computing device, and computer storage medium for detecting IGH rearrangement
BR112023019195A2 (en) 2021-03-24 2023-10-17 Genentech Inc EFFICIENT EDITING OF THE TCR GENE IN T LYMPHOCYTES
CN113637741B (en) * 2021-09-29 2023-12-01 成都二十三魔方生物科技有限公司 Early-onset white hair genetic risk gene detection kit, early-onset white hair genetic risk assessment system and early-onset white hair genetic risk assessment method
WO2024257764A1 (en) * 2023-06-12 2024-12-19 国立大学法人神戸大学 Immune reaction evaluation method
WO2025122939A1 (en) * 2023-12-08 2025-06-12 Dana-Farber Cancer Institute, Inc. Detection and classification of b-cell malignancies
CN117867121A (en) * 2024-01-12 2024-04-12 广州华银医学检验中心有限公司 Primer combination and method for detecting tiny residues in tumor immune repertoire
CN120290752B (en) * 2025-06-13 2025-09-16 北京大学成都前沿交叉生物技术研究院 Capture probe, kit comprising same and use of same in detection of T cell and B cell immune repertoire at spatial resolution

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4942124A (en) 1987-08-11 1990-07-17 President And Fellows Of Harvard College Multiplex sequencing
US5168038A (en) 1988-06-17 1992-12-01 The Board Of Trustees Of The Leland Stanford Junior University In situ transcription in cells and tissues
WO1990004648A1 (en) 1988-10-20 1990-05-03 Alexander Alan Morley Method for diagnosis of monoclonality in leukaemia and lymphoma
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
JP3080178B2 (en) 1991-02-18 2000-08-21 東洋紡績株式会社 Method for amplifying nucleic acid sequence and reagent kit therefor
US5981179A (en) 1991-11-14 1999-11-09 Digene Diagnostics, Inc. Continuous amplification reaction
US5837447A (en) 1992-04-15 1998-11-17 Blood Center Research Foundation, Inc., The Monitoring an immune response by analysis of amplified immunoglobulin or T-cell-receptor nucleic acid
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US6090592A (en) 1994-08-03 2000-07-18 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid on supports
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
US6087096A (en) 1995-11-13 2000-07-11 Dau; Peter C. Method of intrafamily fragment analysis of the T cell receptor α and β chain CDR3 regions
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
KR19990087749A (en) * 1996-03-13 1999-12-27 시오노 요시히코 Human T Cell Clones Specific to Rheumatoid Arthritis
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
CA2257152C (en) 1996-06-03 2009-01-27 Linda M. Pilarski Methods for detection of rearranged dna
EP1033411B1 (en) 1996-06-04 2006-02-22 University of Utah Research Foundation Fluorescent donor-acceptor pair
US5846928A (en) 1996-08-01 1998-12-08 Pasken Products Co., Ltd. Method for treating cancer patients
AU727541B2 (en) 1996-09-06 2000-12-14 Ortho-Mcneil Pharmaceutical, Inc. Purification of antigen-specific T cells
GB9626815D0 (en) * 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
EP3034626A1 (en) 1997-04-01 2016-06-22 Illumina Cambridge Limited Method of nucleic acid sequencing
US6008002A (en) 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
KR100399475B1 (en) 1998-02-12 2003-09-29 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
DE19833738A1 (en) 1998-07-27 2000-02-03 Michael Giesing Process for isolating cancer cells from cell-containing body fluids and kits for performing this process
AR021833A1 (en) 1998-09-30 2002-08-07 Applied Research Systems METHODS OF AMPLIFICATION AND SEQUENCING OF NUCLEIC ACID
US6300070B1 (en) 1999-06-04 2001-10-09 Mosaic Technologies, Inc. Solid phase methods for amplifying multiple nucleic acids
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
EP1227321A1 (en) 2000-12-28 2002-07-31 Institut für Bioanalytik GmbH Reversible MHC multimer staining for functional purification of antigen-specific T cells
GB0128153D0 (en) 2001-11-23 2002-01-16 Bayer Ag Profiling of the immune gene repertoire
JP4708029B2 (en) * 2002-10-11 2011-06-22 エラスマス・ユニバーシティー・ロッテルダム Nucleic acid amplification primers for PCR-based clonality studies
CA2513535C (en) 2003-01-29 2012-06-12 454 Corporation Bead emulsion nucleic acid amplification
AU2003902299A0 (en) 2003-05-13 2003-05-29 Flinders Medical Centre A method of analysing a marker nucleic acid molecule
DE60326052D1 (en) 2003-12-15 2009-03-19 Pasteur Institut Determination of the repertoire of B lymphocyte populations
WO2006017635A2 (en) 2004-08-11 2006-02-16 Albert Einstein College Of Medicine Of Yeshiva University Isolation, gene expression, and chemotherapeutic resistance of motile cancer cells
US8426146B2 (en) * 2005-06-03 2013-04-23 University of Pittsburgh—of the Commonwealth System of Higher Education Multiparameteric method for assessing immune system status
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
US7375211B2 (en) * 2005-11-18 2008-05-20 Kou Zhong C Method for detection and quantification of T-cell receptor Vβ repertoire
US7537897B2 (en) 2006-01-23 2009-05-26 Population Genetics Technologies, Ltd. Molecular counting
CN101225441B (en) * 2007-12-05 2010-12-01 浙江大学 A method for detecting gene composition of clone-specific T lymphocyte TCR BV CDR3
US11051733B2 (en) 2008-01-18 2021-07-06 Wake Forest University Health Sciences Isolating and purifying cells for therapy
EP2088205A1 (en) * 2008-02-11 2009-08-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) PSMB10: A diagnosis marker and therapeutic target of chronic rejection.
US20090226975A1 (en) * 2008-03-10 2009-09-10 Illumina, Inc. Constant cluster seeding
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
EP4335932A3 (en) * 2008-11-07 2024-06-26 Adaptive Biotechnologies Corporation Methods of monitoring conditions by sequence analysis
US8574835B2 (en) 2009-05-29 2013-11-05 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
WO2011106738A2 (en) * 2010-02-25 2011-09-01 Fred Hutchinson Cancer Research Center Use of tcr clonotypes as biomarkers for disease

Also Published As

Publication number Publication date
CA2798431C (en) 2018-10-23
JP6246971B2 (en) 2017-12-13
ES2593614T3 (en) 2016-12-12
CN103097888B (en) 2016-03-09
WO2011139372A1 (en) 2011-11-10
EP3144673A1 (en) 2017-03-22
EP2567226A4 (en) 2013-08-28
ES2740802T3 (en) 2020-02-06
JP6085249B2 (en) 2017-02-22
JP2013524849A (en) 2013-06-20
EP3456847A1 (en) 2019-03-20
EP2567226B1 (en) 2016-08-10
AU2011249041A1 (en) 2012-11-22
EP3456847B1 (en) 2024-12-25
JP2017205112A (en) 2017-11-24
CA2798431A1 (en) 2011-11-10
EP3456847C0 (en) 2024-12-25
SG185128A1 (en) 2012-12-28
JP2013524848A (en) 2013-06-20
JP6158080B2 (en) 2017-07-05
EP4219759A2 (en) 2023-08-02
DK3144673T3 (en) 2019-09-09
JP2018068300A (en) 2018-05-10
EP4219759A3 (en) 2023-09-06
CN104673899A (en) 2015-06-03
EP2567226A1 (en) 2013-03-13
WO2011139371A1 (en) 2011-11-10
AU2011249041B2 (en) 2014-10-30
DK2567226T3 (en) 2016-10-10
EP3144673B1 (en) 2019-07-10
CN103097888A (en) 2013-05-08
JP6533272B2 (en) 2019-06-19

Similar Documents

Publication Publication Date Title
SG10201503534RA (en) Monitoring health and disease status using clonotype profiles
GB201101858D0 (en) Health monitoring
GB2480654B (en) Monitoring handwashing
GB201217109D0 (en) Health pillow
GB201008834D0 (en) Monitoring changes in behaviour of a human subject
EP2895054A4 (en) Mobile cardiac health monitoring
EP2670298A2 (en) Health monitoring
EP2568901A4 (en) Reflectance-facilitated ultrasound treatment and monitoring
ZA201206466B (en) Extruded animal litters
EP2481033A4 (en) Hygiene monitoring systems and methods
GB201004026D0 (en) Slat monitoring system
PL2485026T3 (en) Structural health monitoring system
EP2583651A4 (en) Wheelchair and bed
ZA201103013B (en) Dough extruders and methods
GB2480605B (en) Respiration monitoring device
EP2814409A4 (en) Reflectance-facilitated ultrasound treatment and monitoring
GB2477597B (en) Disinfectant materials and methods
ZA201205474B (en) Non-invasive spectrophotometer and related method
EP2651287A4 (en) Monitoring volaemic condition in a human or animal subject
GB201010315D0 (en) Asset health monitoring
SI2619394T1 (en) Sill and opening-leaf assembly
GB0912370D0 (en) Monitoring individuals
GB201014102D0 (en) Patient compliance monitoring device - pharmaceuticals
GB2482379B (en) Methods and systems for structural health monitoring
TWM388048U (en) Physiological monitoring system